5-Fluoro-7-hydroxy-2,3-dihydro-1H-inden-1-one, 97%, 2g

Propylene glycol monopropyl ether, min 99%, for synthesis, 1L, plastic packaging.

1,4-PIPERIDINEDICARBOXYLIC ACID, 4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, 4-METHYL 1-(PHENYLMETHYL) ESTER, 95.0%, 250mg

1-Bromo-2-(1,1-difluoroethyl)benzene, 95.0%, 250mg

7-METHOXYQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 250mg

3,4-Diaminothiophene, 95.0%, 1g

4-Oxo-4-phenylaminobutanoic acid, 97.0%, 1g

2,3,4,9-Tetrahydro-1h-carbazol-1-amine, 97%, 500mg

1-(tert-Butoxycarbonyl)-2-oxoazetidine-3-carboxylic acid, 98%, 5g

1-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, 95.0%, 10g

5-(Bromomethyl)-2-chloro-3-iodopyridine, 95.0%, 5g

Cobalt(II) bromide, 97%, 500g

ANIRACETAM, 98%, 100mg